3Borel JF, Feurer C, Gubler HU, et al. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 1976;6:468-475
4Calne RY. Cyclosporin A in patients allografts from receiving renal cadaver donors. Lancet 1978;2:1323-1327
5Gjertson DW, Ceckaj M, Tarasaki PI. The relative effects of FK506 and Cyclosporine on short and long term kidney graft survival. Transplantation 1995;60:1384-1389
6Henry ML. Cyclosporine and tacrolimos(FK506):a comparison of efficacy and safety profiles. Clin Transplant 1999;13:209-220
7Halloran PF. Rethinking immunosuppression in terms of the redundant and nonredundant steps in the immune response. Transplant Proc 1996;28:11-14
8Dallman MJ. Molecular biology of the allograft response. Transplant Proc 1996;28:2-4
9Kronke M, Leonard WJ, Depper JM, et al. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A 1984;81:5214-5218
10Granelli-Piperno A. In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A. J Exp Med 1988;168:1649-1658
